| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |